EMJ Podcast: Insights For Healthcare Professionals

In this first podcast, Ali Mobasheri and Daniel White discuss why OA is a serious disease and how it’s burden of disease impacts individuals and society. Conversation focuses on the importance of early-stage diagnosis and why it is an important step in encouraging OA patients to live as disability free as possible. The experts also address how the initial stage of OA condition is often stigmatised, ignored, or downplayed by patients, whilst at the same time recognizing how early lifestyle modification can be an important step in better long-term disease management.

This content has been supported by Viatris

This week, Jonathan is joined by Emma Hallam, Macmillan Consultant Radiographer in Post Treatment & Late Effects at Nottingham Radiotherapy Centre, UK. They discuss Hallam’s career and why her clinic is important for patient who have had cancer. They also discuss the impact that cancer treatment can have on patients, focusing on patient quality of life and symptoms after treatment, and the psychological impact of cancer. 

In this podcast, Hallam comments on the Pelvic Radiation Diseases (PRD) Association’s Best Practice Pathway. Find out more by clicking here. 

This podcast explores the emerging role of precision medicine in metastatic colorectal cancer (mCRC) and its associated treatment algorithms. Experts in the field, Prof. Sebastian Stintzing and Prof. Erika Martinelli, review the updates from the latest European Society of Medical Oncology (ESMO) Clinical Practice Guideline for the management of patients with mCRC, touching on key developments and how these translate to the current procedures of precision medicine treatment used in clinical practice.

This podcast is not intended for audiences from the UK. Unrestricted funding for the medical education activity has been provided by Pierre Fabre

This week, Jonathan is joined by Steven Feldman, Professor of Dermatology and Pathology at Wake Forest University School of Medicine in Winston-Salem, North Carolina, USA. The pair discuss Feldman’s research into psoriasis and its treatments, including the use of tanning beds, as well as Feldman’s interest in patient compliance and patient satisfaction.  

In this EMJ podcast episode, David O’Malley, Director of Gynecologic Oncology, Ohio State University, and the James Comprehensive Cancer Center, Columbus, Ohio, USA, and Christina Fotopoulou, Consultant Gynaecological Oncologist, Queen Charlotte’s & Chelsea Hospital, London, UK, discuss the role of homologous recombination deficiency (HRD) testing, and the progress of poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer.

The publication of this podcast was funded by a medical educational grant from AstraZeneca with the purpose of enhancing the fundamental understanding of oncology specialists of the role and value of homologous recombination deficiency (HRD) testing and progress in the use of poly(ADP-ribose) polymerase (PARP) inhibitors.

This EMJ podcast explores key topics addressed at the European Respiratory Society (ERS) International Congress 2022, during a symposium entitled ‘Re-IMAGinING the pathway for clinical decision making in rare lung disease – moving towards a united vision’. Focusing on key questions, including the unmet needs in interstitial lung disease, the value of data repositories for enhancing patient care in rare lung diseases, and the impact of exacerbation physiology on imaging parameters   The podcast is co-chaired by Charlie Strange, Professor of Pulmonary and Critical Care Medicine, and Daiana Stolz, Medical Director of the Clinic for Pneumology and Professor of Medicine, who are joined by guest Elizabeth Estes, Executive Director of the Open Source Imaging Consortium (OSIC).

This podcast has been sponsored by CSL Behring.

In this episode of the EMJ Podcast, Brigitte Scott hosts Gilles Freyer, Medical Oncologist, Lyon University Hospital, France; and Domenica Lorusso, Associate Professor of Obstetrics and Gynecology, Catholic University of Rome, Italy, and responsible for Clinical Research Development at the Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. Freyer and Lorusso provide expert perspectives on the research outcomes, updates, and advancements in ovarian cancer management that were presented at the European Society for Medical Oncology (ESMO) Congress 2022, which took place on 9th–13th September, in Paris, France.

This podcast was funded by a medical educational grant from GSK, with the purpose of enhancing the fundamental understanding of oncology specialists of key data and the latest advancements in ovarian cancer care.

In this week’s episode, Jonathan Sackier is joined by Annalisa Jenkins, a biopharma thought leader with over 25 years of experience in the industry.  The pair discuss Jenkins’  time in the Royal Navy, her role as non-executive director of Genomics England, and how connecting human and financial capital can help create an environment conducive to success.

On this week’s episode of the EMJ Podcast, our host Jonathan is joined by Bruce Gewertz, Surgeon-in-Chief, Chair of the Department of Surgery, Vice-Dean for Academic Affairs, and Vice-President for Interventional Services at Cedars-Sinai Health System, Los Angeles, USA. They discuss Gewertz’s 40-year-long career in vascular surgery and academic medicine, as well as pertinent topics including burnout in healthcare professionals, self-doubt, and ensuring the establishment of a work-life balance. An anecdote about Bruce and Jonathan’s mutual friend, George Berci, who is still practicing at the age of 101, addresses fulfilment in medicine.

In this special episode, Evgenia Koutsouki, Editor of the EMJ family of journals, reflects on the most interesting and noteworthy moments of past 3 months on the EMJ podcast. Covering topics from research into childhood leukaemia to a deep dive into consciousness, this podcast looks back on the most fascinating insights provided by our guests.